Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017705
Filing Date
2025-06-18
Accepted
2025-06-18 16:57:19
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 form4-06182025_080615.html 4  
1 form4-06182025_080615.xml 4 5659
  Complete submission text file 0001415889-25-017705.txt   7026
Mailing Address 28903 NORTH AVENUE PAINE VALENCIA CA 91355
Business Address
Shannon James Samuel (Reporting) CIK: 0001485417 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 251057629

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)